Neutrophil-to-lymphocyte Ratio and Monocyte-to-eosinophil Ratio As Prognostic Indicators for Advanced Nasopharyngeal Carcinoma

Overview

Journal Eur Arch Otorhinolaryngol

Specialty Otorhinolaryngology

Date 2024 Feb 5

PMID 38315178

Authors

Maoyu Ye

Aijie Huang

Bo Yuan

Guolin Tan

Jingang Ai

Honghui Liu

Affiliations

Soon will be listed here.

Abstract

Objective: To determine the predictive value of the neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), neutrophil-to-eosinophil ratio (NER), lymphocyte-to-eosinophil ratio (LER), monocyte-to-eosinophil ratio (MER), systemic inflammatory response index (SIRI), and ratio of inflammatory cells before and after treatment for predicting survival in advanced nasopharyngeal carcinoma (NPC) and to provide a reference for treatment.

Methods: A retrospective review of 70 patients was performed. Serological indexes were obtained by drawing blood before and after systemic therapy. The cutoff values of these indexes were determined by receiver operating characteristic (ROC) curves. The prognostic value of the indexes for overall survival (OS) and distant metastasis free survival (DMFS) was evaluated.

Results: Survival analysis showed that a smaller pretreatment LMR value was associated with poor OS; larger pretreatment NER, LER, MER, and SIRI values were associated with poor OS; a smaller posttreatment LMR value was associated with poor OS; larger posttreatment NLR, NER, MER, and SIRI values were associated with poor OS; a smaller pretreatment LMR value was associated with poor DMFS; larger pretreatment NLR, NER, LER, and MER values were associated with poor DMFS; and larger posttreatment NLR, NER, LER, and MER values were associated with poor DMFS. Furthermore, a larger neutrophil after treatment-to-neutrophil before treatment ratio was associated with poor OS and DMFS. Logistic regression analysis showed that pretreatment MER and posttreatment NLR were independent predictors of OS in patients with advanced NPC; moreover, pretreatment and posttreatment MER and NLR were independent prognostic factors for DMFS in patients with advanced NPC.

Conclusions: The NLR, NER and MER can be used to predict survival in advanced NPC patients. Eosinophils might be one of the factors for the good prognosis of NPC patients. In addition, an increased number of neutrophils after treatment may indicate a favorable prognosis.

Citing Articles

Analysis of Prognostic Factors for Internal Carotid Artery Invasion by Nasopharyngeal Carcinoma.

Lien C, Yeh S, Cheng C, Chiang F, Hwang T, Cai B Cancers (Basel). 2025; 17(3).

PMID: 39941853 PMC: 11816255. DOI: 10.3390/cancers17030488.

A clinical-radiomics nomogram based on multisequence MRI for predicting the outcome of patients with advanced nasopharyngeal carcinoma receiving chemoradiotherapy.

Chen L, Wang Z, Meng Y, Zhao C, Wang X, Zhang Y Front Oncol. 2024; 14:1460426.

PMID: 39634263 PMC: 11615067. DOI: 10.3389/fonc.2024.1460426.

Prognostic Value of Neutrophil-to-Eosinophil Ratio (NER) in Cancer: A Systematic Review and Meta-Analysis.

Sahin T, Ayasun R, Rizzo A, Guven D Cancers (Basel). 2024; 16(21).

PMID: 39518127 PMC: 11545344. DOI: 10.3390/cancers16213689.

Prognostic Study of Inflammatory Markers in Nasopharyngeal Carcinoma Patients Receiving Intensity-Modulated Radiotherapy.

Tang L, Li X, Wang Y, Tong Y Cancer Manag Res. 2024; 16:1321-1328.

PMID: 39372707 PMC: 11451463. DOI: 10.2147/CMAR.S481142.

High Expression of NLR and SII in patients With Nasopharyngeal Carcinoma as Potential Prognostic Observations.

Lv H, Chen X, Chen X, Li J, Lu X Cancer Control. 2024; 31:10732748241288106.

PMID: 39323032 PMC: 11440550. DOI: 10.1177/10732748241288106.

References

Chen Y, Chan A, Le Q, Blanchard P, Sun Y, Ma J . Nasopharyngeal carcinoma. Lancet. 2019; 394(10192):64-80. DOI: 10.1016/S0140-6736(19)30956-0. View

Zhong L, Dong D, Fang X, Zhang F, Zhang N, Zhang L . A deep learning-based radiomic nomogram for prognosis and treatment decision in advanced nasopharyngeal carcinoma: A multicentre study. EBioMedicine. 2021; 70:103522. PMC: 8365370. DOI: 10.1016/j.ebiom.2021.103522. View

Pan J, Ng W, Zong J, Lee S, Choi H, Chan L . Prognostic nomogram for refining the prognostication of the proposed 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy. Cancer. 2016; 122(21):3307-3315. PMC: 5524130. DOI: 10.1002/cncr.30198. View

Sun X, Su S, Chen C, Han F, Zhao C, Xiao W . Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities. Radiother Oncol. 2013; 110(3):398-403. DOI: 10.1016/j.radonc.2013.10.020. View

Pfister D, Spencer S, Adelstein D, Adkins D, Anzai Y, Brizel D . Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2020; 18(7):873-898. DOI: 10.6004/jnccn.2020.0031. View

Chen Y, Wang Z, Chen L, Liu X, Tang L, Mao Y . A Bayesian network meta-analysis comparing concurrent chemoradiotherapy followed by adjuvant chemotherapy, concurrent chemoradiotherapy alone and radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma. Ann Oncol. 2014; 26(1):205-211. DOI: 10.1093/annonc/mdu507. View

Hong X, Liu N, Liang Y, He Q, Yang X, Lei Y . Circular RNA CRIM1 functions as a ceRNA to promote nasopharyngeal carcinoma metastasis and docetaxel chemoresistance through upregulating FOXQ1. Mol Cancer. 2020; 19(1):33. PMC: 7023763. DOI: 10.1186/s12943-020-01149-x. View

Wu G, Yao Y, Bai C, Zeng J, Shi D, Gu X . Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non-small cell lung cancer patients. Thorac Cancer. 2015; 6(3):275-87. PMC: 4448393. DOI: 10.1111/1759-7714.12178. View

Yapar A, Tokgoz M, Yapar D, Atalay I, Ulucakoy C, Safak Gungor B . Diagnostic and prognostic role of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and lymphocyte/monocyte ratio in patients with osteosarcoma. Jt Dis Relat Surg. 2021; 32(2):489-496. PMC: 8343865. DOI: 10.52312/jdrs.2021.79775. View

10.

Miyahara Y, Takashi S, Shimizu Y, Ohtsuka M . The prognostic impact of neutrophil-to-lymphocyte ratio (NLR) and lymphocyte-to-monocyte ratio (LMR) in patients with distal bile duct cancer. World J Surg Oncol. 2020; 18(1):78. PMC: 7178599. DOI: 10.1186/s12957-020-01847-2. View

11.

Xia L, Li W, Zhai J, Yan C, Chen J, Yang H . Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, lymphocyte-to-monocyte ratio and prognostic nutritional index for predicting clinical outcomes in T1-2 rectal cancer. BMC Cancer. 2020; 20(1):208. PMC: 7066735. DOI: 10.1186/s12885-020-6698-6. View

12.

Lu A, Li H, Zheng Y, Tang M, Li J, Wu H . Prognostic Significance of Neutrophil to Lymphocyte Ratio, Lymphocyte to Monocyte Ratio, and Platelet to Lymphocyte Ratio in Patients with Nasopharyngeal Carcinoma. Biomed Res Int. 2017; 2017:3047802. PMC: 5340935. DOI: 10.1155/2017/3047802. View

13.

Rosenberg H, Dyer K, Foster P . Eosinophils: changing perspectives in health and disease. Nat Rev Immunol. 2012; 13(1):9-22. PMC: 4357492. DOI: 10.1038/nri3341. View

14.

Rothenberg M, Hogan S . The eosinophil. Annu Rev Immunol. 2006; 24:147-74. DOI: 10.1146/annurev.immunol.24.021605.090720. View

15.

Ownby H, Roi L, Isenberg R, Brennan M . Peripheral lymphocyte and eosinophil counts as indicators of prognosis in primary breast cancer. Cancer. 1983; 52(1):126-30. DOI: 10.1002/1097-0142(19830701)52:1<126::aid-cncr2820520123>3.0.co;2-y. View

16.

Ishibashi S, Ohashi Y, Suzuki T, Miyazaki S, Moriya T, Satomi S . Tumor-associated tissue eosinophilia in human esophageal squamous cell carcinoma. Anticancer Res. 2006; 26(2B):1419-24. View

17.

FORSBY N, Klein G, Henle W . Relationship between the Epstein-Barr virus and undifferentiated nasopharyngeal carcinoma: correlated nucleic acid hybridization and histopathological examination. Int J Cancer. 1977; 20(4):486-94. DOI: 10.1002/ijc.2910200403. View

18.

Lin D, Meng X, Hazawa M, Nagata Y, Varela A, Xu L . The genomic landscape of nasopharyngeal carcinoma. Nat Genet. 2014; 46(8):866-71. DOI: 10.1038/ng.3006. View

19.

Ward M, Pan W, Cheng Y, Li F, Brinton L, Chen C . Dietary exposure to nitrite and nitrosamines and risk of nasopharyngeal carcinoma in Taiwan. Int J Cancer. 2000; 86(5):603-9. DOI: 10.1002/(sici)1097-0215(20000601)86:5<603::aid-ijc1>3.0.co;2-h. View

20.

Balkwill F, Mantovani A . Inflammation and cancer: back to Virchow?. Lancet. 2001; 357(9255):539-45. DOI: 10.1016/S0140-6736(00)04046-0. View